Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 26 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE DECROUEZ from Rixensart, company number BE0427257284, closed financial year 2025 with a result of € -118,495 after tax. For that financial year PHARMACIE DECROUEZ recorded a gross margin of € 228,425 and equity of € -154,237. Compared with financial year 2024, the result moved from € -7,664 to € -118,495. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 13, 2026.
€ -154,237
▼ € 118,495 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -118,495
▼ 1446 % more loss than in 2024
Profit after tax over the fiscal year.
€ 19,222
▼ 73% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -276,052.
People and assets in 2025
4.3
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 284,548
▼ 4% vs 2024
€ 66,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,751
▼ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 464,184
▼ 5% vs 2024
€ 22,370 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 387,056
▲ 61% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,125
▼ 29% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 338,209 | € 338,500 | € 357,040 | € 228,425 | ▼ 36% |
| Profit after taxes | € -63,548 | € -20,614 | € -7,664 | € -118,495 | ▼ € 110,831 |
| Equity | € -7,465 | € -28,079 | € -35,743 | € -154,237 | ▼ € 118,495 |
| Total debts | € 907,195 | € 1,076,591 | € 928,238 | € 955,275 | ▲ 3% |
| Cash | € 72,851 | € 13,795 | € 71,919 | € 19,222 | ▼ 73% |
| Land & buildings | € 351,917 | € 321,088 | € 315,909 | € 291,802 | ▼ 8% |
| Retained profit | € -129,280 | € -149,893 | € -157,557 | € -276,052 | ▼ € 118,495 |
| Bank debt | € 556,544 | € 517,734 | € 489,612 | € 464,184 | ▼ 5% |
| Balance sheet total | € 899,730 | € 1,048,513 | € 892,496 | € 801,037 | ▼ 10% |
| Employees (FTE) | 4.8 | 4.5 | 4.5 | 4.3 | ▼ 0.2 |
Key figures of PHARMACIE DECROUEZ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DECROUEZ?
What happened at PHARMACIE DECROUEZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- JUMIEL SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 118,495. filed late Source: NBB ↗
- CAMELOU SRL stepped down as director. NBB
- JUMIEL SRL became a director. NBB
- CAMELOU SRL became a director. NBB
- New establishment in Rixensart. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,548 loss in 2022 to € 118,495 loss in 2025.
On average € 53,100 of value added per employee in 2025.
Management
The stake of CAMELOU comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DECROUEZThe shares are held by CAMELOU (99%).
Directors
According to the 2025 annual accounts
Director · represented by Pascal Martin, Maryline Cosse
Also active at: PHARMACIE MARTIN-COSSE, BVPM DISTRIBUTION
since 2020 · until 2026
Managing director · represented by Jules Frenois
since 2026 · until 2032
Shareholders
99%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Haute 48
1330 Rixensart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0427.257.284
- VAT number
- BE 0427.257.284
- Registered office
- Rue Haute 48, 1330 Rixensart
- Names & denominations
- PHARMACIE DECROUEZ
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 May 1985
- Peppol
- Active · Active since 3 Apr 2026
- Contact
- decrouez.be [email protected] 02 655 14 40
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers